genomebiology.com

Table 1
Patient overview and tumor status
Patient ID	Gender	Type	Primary tumor grade	Metastasis resection^a	Treatment^b

Patient 1	Female	Adenocarcinoma	Moderately differentiated	3 months	No treatment
Patient 2	Male	Adenocarcinoma	Moderately differentiated	20 months	No treatment
Patient 3	Male	Adenocarcinoma	Poorly differentiated	10 months	XELOX^cand Bevacizumab
Patient 4	Female	Adenocarcinoma	Well differentiated	9 months	5FU, leucovorin, oxaliplatin, bevacizumab

^aTime between primary resection and metastasis resection. ^bTreatment after primary tumor resection. ^cCapecitabine and oxaliplatin. 5FU, fluorouracil.
Kloosterman et al. Genome Biology 2011 12:R103 doi:10.1186/gb-2011-12-10-r103

Table 1